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ABSTRACT
This study investigated the hypothesis that the genotype distribution of Legionella isolates from
sporadic patients with Legionnaires’ disease differs from that of Legionella strains in the environment.
An ampliﬁed fragment-length polymorphism (AFLP) assay was used to genotype patient-derived and
environmental Legionella isolates. The three Legionella pneumophila genotypes isolated most frequently
from human respiratory secretions were AFLP types 004 Lyon, 010 London and 006 Copenhagen.
These genotypes were cultured signiﬁcantly less frequently from environmental samples (50% vs. 4%;
p <0.001). The most frequently observed L. pneumophila serogroup 1 genotype among patient-derived
isolates was 004 Lyon (32%). This genotype was cultured from only one of 6458 environmental
samples. The positive sample contained 1.26 · 106 CFU ⁄mL and originated from a whirlpool spa that
had not been disinfected and had been maintained at 36C for several months. Overall, the
distribution of genotypes differed signiﬁcantly among patient and environmental isolates. A possible
explanation is that virulent strains may exist in potential environmental sources at undetectable
concentrations.
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INTRODUCTION
Legionnaires’ disease (LD) is an acute bacterial
pneumonia caused by Legionella spp., and
accounts for 8–13% of community-acquired pneu-
monias [1,2]. Worldwide, >90% of cases of LD are
caused by Legionella pneumophila, of which 92%
are caused by L. pneumophila serogroup 1 [3].
A major transmission route for LD involves
inhalation of the bacterium [4], but drinking and
subsequent aspiration of contaminated water has
also been shown to be a route of transmission
[5,6]. For inhalation to occur, the bacterium must
be disseminated as an aerosol from either natural
or man-made sources in aquatic environments.
Legionella spp. have been cultured from surface
water [7] and ground water [8], where they
ﬂourish as parasites of amoebae and other proto-
zoa [9]. Inadequate ﬁltering and disinfection of
water sources for drinking water production can
lead to the colonisation of water systems by
Legionella spp. [10]. Stagnant water, bioﬁlm for-
mation and favourable growth conditions can
subsequently lead to high bacterial concentra-
tions. Transmission to humans becomes possible
if aerosol-producing devices are connected to
such contaminated water systems.
Contaminated water systems and devices
associated with LD patients include cooling tow-
ers of air-conditioning systems [11], whirlpool
spas [12], showerheads [13], evaporative condens-
ers [14], humidiﬁers [15] and mist-making
machines [16]. These sources were revealed in
outbreak investigations that included epidemio-
logical studies and comparison of Legionella geno-
types isolated from patient specimens and the
environment. Genotype comparisons have an
important role in judging the likelihood of a
source of infection being the true source of LD,
since indistinguishable genotypes have been
identiﬁed from sources over periods of up to
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17 years [17]. Such interpretations are often made
without a full understanding of the underlying
distribution of genotypes in the patient-derived
and environmental populations [18]. However,
this distribution can vary from a single endemic
genotype, such as that found in the entire water
distribution system in Paris, France [19], to the
occurrence of several different environmental
genotypes in a single hospital in Italy [20].
The aim of the present study was to test the
hypothesis that the genotype distribution of Legio-
nella isolates from sporadic patientswith LDdiffers
from the genotype distribution of Legionella isolates
from the environment. This reﬂects the observation
that virulence factors are more prominent in
patient-derived Legionella isolates [21]. Accord-
ingly, a 4-year prospective national study was
performed to systematically compare the genotype
distribution of Legionella isolates from sporadic
cases to the genotype distribution of Legionella
isolates cultured from the environmental sources
towhich theLDpatientswere exposedduring their
incubation period. Potential sources of bias and




LD has been a notiﬁable disease in The Netherlands since 1
July 1987. Attending physicians are required to report cases
of LD to a public health physician at one of the 38 Regional
Public Health Services within 24 h of diagnosis. The public
health physicians are then required to report all conﬁrmed
and probable cases of LD to the Ministry of Health within
24 h. The international criteria speciﬁed by the European
Working Group for Legionella Infections (EWGLI) for con-
ﬁrmed and probable cases of LD [22] are used in The
Netherlands. The present study included cases of LD notiﬁed
between 1 August 2002 and 30 October 2006 that had a
laboratory diagnosis which included isolation of Legionella
spp. from sputum or lung secretions. As the aim of the study
was to investigate differences in the distribution of Legionella
genotypes in The Netherlands, patients who had travelled
abroad for ‡5 days during their incubation period of
2–10 days were excluded. In addition, to avoid an over-
representation of genotypes associated with clusters or
outbreaks, only one randomly selected LD patient was
included from each EWGLI-deﬁned cluster or outbreak of
infection [23]. A subgroup of patients whose pulmonary
secretions yielded the most frequently observed ampliﬁed
fragment-length polymorphism (AFLP) Legionella genotype
(see Results) was compared with a control group of LD
patients using a nine-page questionnaire. The questionnaire
requested information concerning general health status and
exposure to aerosols originating from any water source (e.g.,
shower, whirlpool, sprinkler, hose, fountain, air-conditioning
system, heating system) at home, at work, during leisure
activities and during holiday periods. The same data had
been systematically collected previously from 68 patients
with community-acquired LD who had been resident in The
Netherlands for ‡5 days during the incubation period [24].
Bacteria
Following a large outbreak of infection in The Netherlands
that involved 188 patients with LD [25], a national outbreak
detection programme (NODP) was started on 1 August 2002
[26], with the aim of providing a short response time between
the diagnosis of LD patients and the inspection and sampling
of potential sources of infection. To identify potential sources
during the incubation period, medical specialists in infectious
disease control at the Regional Public Health Services carry
out structured interviews (using a questionnaire) with the
patient and ⁄ or a contact. The interviews focus on tracking
each patient’s exposure to potential sources of infection.
Certain potential sources mentioned speciﬁcally in the ques-
tionnaire, e.g., swimming pools and saunas, were included on
the basis of previous epidemiological and outbreak studies
[26].
Following the identiﬁcation of a potential source, trained
laboratory staff from the NODP take water and swab samples,
which are then cultured for the presence of Legionella spp. The
samplingyield is expressedas thenumberof isolates included in
the study divided by the number of samples taken. Criteria for
sampling were revised for budgetary reasons from 1 June 2006
onwards, thereby creating a natural end to the inclusion period
for environmental Legionella isolates in the present study.
Isolate characteristics
Patient isolates were sent by all 62 medical microbiology
laboratories in The Netherlands that are involved in the
diagnosis and treatment of pneumonia patients to the Regional
Public Health Laboratory Kennemerland (Haarlem), where
they were stored at )70C. L. pneumophila was cultured on
buffered charcoal yeast extract agar supplemented with
a-ketoglutarate [27], with dyes and with and without the
antibiotics polymyxin B, anisomysin and vancomycin (Legio-
nella MWY Selective Supplement SR 110, 111, and 118; Oxoid,
Basingstoke, UK). Water and swab samples from potential
sources that had been collected by environmental sampling
were cultured and serotyped as described previously [26].
L. pneumophila serogroup 1 patient and environmental
isolates were genotyped by AFLP analysis, as recommended
by EWGLI [28]. Proﬁles for 31 deﬁned EWGLI AFLP types are
available from the EWGLI website (http://www.
ewgli.org). The entire NODP dataset, including isolates from
previous studies, contains 42 genotypes that have not yet been
designated by EWGLI. Therefore, for the purpose of this study
using the EWGLI AFLP protocol, provisional Not Yet Desig-
nated (NYD) numbers were assigned, starting with NYD01
and ending with NYD42.
Inclusion bias
The residence of a patient was used as a proxy for the place of
infection unless a patient had resided elsewhere for ‡5 days
during the incubation period. The place of infection was
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subsequently classiﬁed, using the province of residence as the
geographical subunit, into four regions that conformed to the
criteria of Statistics Netherlands [29], i.e., North (Friesland,
Groningen, Drenthe), East (Overijssel, Gelderland, Flevoland),
West (Noord-Holland, Utrecht, Zuid-Holland, Zeeland) and
South (Noord-Brabant, Limburg). The environmental isolates
were similarly grouped. To explore any potential diagnostic
bias, incidence rates for culture-proven LD were calculated for
the four regions and compared to the mean incidence rate of
LD for 2002–2006 in these regions. To explore any potential
inclusion bias for environmental isolates, the number of
identiﬁed and sampled potential sources was compared for
the four regions.
Temperature has an inﬂuence on the growth of Legionella
spp., both in the natural environment [30] and in the man-
made environment [31]. The level of humidity may also be
a factor in the transmission of LD [32]. Therefore, data
concerning temperature and humidity were included as a
potential source of bias and confounding in the analyses. A
proxy was used as the day of infection, for which the
humidity and temperature were determined. This was calcu-
lated by subtracting a median incubation period of 5 days
from the ﬁrst day of illness. In practice, there is a delay
between the day of diagnosis and the day of sampling. If the
delay is distributed unevenly over the different regions of
The Netherlands, bias caused by seasonal differences could
occur. The mean, minimum and maximum temperatures, and
the relative degree of humidity, were recorded for the
calculated day of infection and for the day of sampling.
These were compared to those of the other days of the study
period.
Statistical analyses
Univariate analysis was used to estimate crude regional
differences in AFLP genotype distribution among patient
and environmental isolates. Comparison of risk-factors for
LD between two groups of LD patients was analysed
by univariate analysis, using Student’s t-test for continuous
variables and the Pearson chi-square test for dichotomous
and nominal variables. For continuous variables, the distri-
butions were checked for normality. Statistical analyses




Between 1 August 2002 and 30 October 2006, 1133
patients with LD were notiﬁed by the Ministry of
Health. Of these, 691 (61%) had been abroad for
‡5 days during the incubation period and were
therefore excluded. Of the remaining 442 patients,
128 (29%) diagnoses were conﬁrmed by isolation
of Legionella spp. from sputum or lung secretions.
Eleven of these patients were representatives of
outbreaks. Serotyping and genotyping results for
the isolates from the remaining 117 patients are
summarised in Table 1.
Clinical and environmental isolates
Between 1 August 2002 and 30 May 2006, sam-
pling was required for 442 notiﬁed cases of LD
who had spent ‡5 days in The Netherlands. Of
these, four foreign visitors could not be inter-
viewed because they had already left the country,
and 35 (8%) patients refused sampling for various
reasons, mostly privacy-related. For the remain-
ing 403 LD patients, 875 potential sources of
infection were identiﬁed, all of which were
sampled. In total, 185 (21%) potential sources
yielded one or more different Legionella strains,
giving a total of 245 patient-related environmental
isolates to be serotyped and genotyped. These 245
isolates were cultured from 6458 samples, giving
a yield of 3.8%. The yield was signiﬁcantly higher
in the western region than in the other regions
(4.7% vs. 3.1%; p 0.001; Table 2). Also, the yield
for L. pneumophila serogroup 1 was signiﬁcantly
higher in this region (1.0% vs. 0.6%; p 0.02;
Table 2). The origins of the 6458 samples are
shown in Table 3.
Isolate characteristics
In 18 instances, a clinical isolate was genotypically
indistinguishable from an environmental Legio-
nella isolate. In total, 13 sources were involved,
nine of which were related to sporadic cases of
LD. Four of the sources were related to clusters
involving two to four patients, totalling 13 LD
patients. As shown in Table 1, serogroup 1
accounted for 88% of all patient isolates, com-
pared to only 20% of all environmental isolates
(p <0.001). The three genotypes isolated most
frequently from human sputum or lung secretions
were AFLP types 004 Lyon, 010 London and 006
Copenhagen, and these genotypes were also
cultured signiﬁcantly less frequently from envi-
ronmental samples (50% vs. 4%, p <0.001). The
over-representation of LD patients from the
western part of The Netherlands did not inﬂuence
the overall distribution pattern.
When 33 patients whose pulmonary secretions
yielded AFLP genotype 004 Lyon were compared
with 68 control LD patients, the mean age of the
AFLP 004 Lyon patients was signiﬁcantly higher
than that of the controls (mean difference 8 years;
t-test for equality of means, p 0.03), and the
male-to-female ratio was 3.7, compared with 3.5
for controls (p 0.64), but none of the other host
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or environmental risk-factors included in the
questionnaire differed signiﬁcantly between the
two groups.
AFLP 004 Lyon was cultured from only one of
the 6458 environmental samples. This sample
originated from an outdoor whirlpool spa in the
eastern region of The Netherlands. The spa had
not been disinfected and was maintained at 36C
for several months, resulting in a bacterial con-
centration of 1.26 · 106 CFU ⁄L at the time of
sampling. AFLP 010 London was not found in
any of the environmental samples. AFLP 006
Copenhagen was cultured on one occasion from a
ﬁre hose that was used for cleaning purposes.
The AFLP type ‘not yet designated’ was further
divided into subtypes NYD01–NYD42. Seventeen
Table 2. Numbers of culture-positive patients with Legionnaires’s disease (LD) and environmental Legionella isolates,
grouped according to their geographical location among four regions in The Netherlands (2002–2006)
Characteristic
Region
North East West South Total
Surface area in km2 11 367 (27) 10 947 (26) 12 331 (29) 7314 (17) 41 959 (100)
Inhabitantsa 1 698 865 (10) 3 432 345 (21) 7 580 493 (47) 3 546 329 (22) 16 258 032 (100)
No. of notiﬁed LD patients staying in The Netherlands 35 (8) 84 (20) 189 (45) 114 (27) 422 (100)
No. of patient isolates 6 (5) 18 (15) 65 (56) 28 (24) 117 (100)
No. of environmental samples taken 457 (7) 1277 (20) 2858 (44) 1866 (29) 6458 (100)
No. of environmental Legionella isolates 20 (8) 32 (13) 133 (54) 60 (25) 245 (100)
No. of environmental L. pneumophila serogroup 1 isolates 2 (4) 4 (8) 30 (60) 14 (28) 50 (100)
No. of environmental L. pneumophila serogroup 2–14 isolates 2 (4) 12 (22) 33 (60) 8 (14) 55 (100)
No. of environmental non-L. pneumophila isolates 16 (11) 16 (11) 70 (50) 38 (28) 140 (100)
aAccording to the 2004 National Census.
Values in parentheses are percentages.
Table 1. Serotyping and genotyp-
ing results for 117 Legionella isolates
from patients with Legionnaires’






Legionella non-pneumophila 2 (2) 140 (57)
L. pneumophila non-serogroup 1 12 (10) 55 (23)
L. pneumophila serogroup 1, AFLP type 004 Lyon 33 (28) 1 (0.4)
L. pneumophila serogroup 1, AFLP type ‘not yet designated’ 22 (19) 11 (4)
L. pneumophila serogroup 1, AFLP type NYD01 ) 2
L. pneumophila serogroup 1, AFLP type NYD02 1 1
L. pneumophila serogroup 1, AFLP type NYD03 1 1
L. pneumophila serogroup 1, AFLP type NYD04 3 –
L. pneumophila serogroup 1, AFLP type NYD06 1 –
L. pneumophila serogroup 1, AFLP type NYD09 1 –
L. pneumophila serogroup 1, AFLP type NYD11 1 –
L. pneumophila serogroup 1, AFLP type NYD16 1 –
L. pneumophila serogroup 1, AFLP type NYD17 1 –
L. pneumophila serogroup 1, AFLP type NYD20 1 –
L. pneumophila serogroup 1, AFLP type NYD22 1 –
L. pneumophila serogroup 1, AFLP type NYD23 2 1
L. pneumophila serogroup 1, AFLP type NYD24 – 2
L. pneumophila serogroup 1, AFLP type NYD25 1 –
L. pneumophila serogroup 1, AFLP type NYD28 1 –
L. pneumophila serogroup 1, AFLP type NYD31 – 1
L. pneumophila serogroup 1, AFLP type NYD32 – 1
L. pneumophila serogroup 1, AFLP type NYD33 1 –
L. pneumophila serogroup 1, AFLP type NYD34 – 1
L. pneumophila serogroup 1, AFLP type NYD36 1 –
L. pneumophila serogroup 1, AFLP type NYD38 1 –
L. pneumophila serogroup 1, AFLP type NYD39 1 –
L. pneumophila serogroup 1, AFLP type NYD40 1 –
L. pneumophila serogroup 1, AFLP type NYD41 – 1
L. pneumophila serogroup 1, AFLP type NYD42 1 –
L. pneumophila serogroup 1, AFLP type 010 London 11 (9) –
L. pneumophila serogroup 1, AFLP type 006 Copenhagen 8 (6) 1 (0.4)
L. pneumophila serogroup 1, AFLP type 003 Glasgow 7 (6) 5 (2)
L. pneumophila serogroup 1, AFLP type 013 London 7 (6) 7 (3)
L. pneumophila serogroup 1, AFLP type 028 Rome 4 (3) 12 (5)
L. pneumophila serogroup 1, AFLP type 001 Lugano 3 (3) 6 (2)
L. pneumophila serogroup 1, AFLP type 008 Stockholm 3 (3) 2 (0.8)
L. pneumophila serogroup 1, AFLP type 009 London 2 (2) 4 (2)
L. pneumophila serogroup 1, AFLP type 017 Lugano 2 (2) 1 (0.4)
L. pneumophila serogroup 1, AFLP type 015 Dresden 1 (1) –
Total 117 (100) 245 (100)
Values in parentheses are percentages.
462 Clinical Microbiology and Infection, Volume 14 Number 5, May 2008
 2008 The Authors
Journal Compilation  2008 European Society of Clinical Microbiology and Infectious Diseases, CMI, 14, 459–466
of the 19 different NYD types were isolated from
lung secretions and were unique, while NYD04
and NYD23 were isolated on three and two
occasions, respectively. Type NYD04 was not
cultured from environmental samples. Of nine
different NYD types cultured from environmental
samples, only three were also cultured from lung
secretions (Table 1).
Inclusion bias
The results shown in Table 2 reveal that LD
patients living in the West region were more
likely to have their diagnosis conﬁrmed by isola-
tion of Legionella spp. than patients living in other
regions (34% vs. 22%; p 0.05). Therefore, isolates
from the western part of the country were over-
represented in the collection of patient isolates.
However, since the genotype distribution of the
isolates from the West region did not differ from
that in the rest of the country, the overall
genotype distribution was not inﬂuenced.
The results in Table 2 revealed no signiﬁcant
differences between the percentage of samples
taken in each region and the percentages of
notiﬁed LD patients. Therefore, no selection bias
in sampling procedure was apparent.
There were no signiﬁcant differences in the
maximum or mean temperatures, relative humid-
ity or hours of sunshine between the day of
sampling and the other days of the study period.
Similarly, there was no difference in terms of the
calculated days of infection compared with the
other days of the study period. However, signif-
icant differences were observed on the days on
which two LD patients were presumed to have
been infected (Table 4).
DISCUSSION
Based on the results of this study, it was con-
cluded that the genotype distribution of Legionella
isolates from sporadic LD patients in The Neth-
erlands differs from the genotype distribution of
Legionella isolates in the environment. Previous
studies in various countries have suggested that
differences in distribution patterns may exist [33–
36], but these studies were not based on a
systematic collection of both patient and environ-
mental Legionella isolates.
In total, 50% of the L. pneumophila serogroup 1
isolates from LD patients were represented by
only three EWGLI AFLP genotypes, but these
genotypes represented only 4% of environmental
serogroup 1 isolates. This ﬁnding suggests that
these genotypes are more virulent than others.
AFLP genotype 004 Lyon, which was isolated
most frequently from human lung secretions,
does not seem to deﬁne a clinically or environ-
mentally distinct subgroup of LD patients, except
Table 3. Origins of 6458 environ-
mental samples, grouped according
to building category, installation





Cold Hot Otherb Cold Hot Other Cold Hot Other
Industry and commercec 211 66 96 31 24 43 53 6 124 654
Recreationd 143 35 42 68 40 156 25 2 31 542
Buildings and garden centres 22 3 14 1 1 2 48 0 116 207
Healthcare facility 52 34 19 41 31 51 1 0 12 241
Private house 1580 756 362 687 611 717 37 1 63 4814
Total 2008 894 533 828 707 969 164 9 346 6458
aFire hose, aquarium, high-pressure spraying device, private well, natural water, fountain, evaporative condenser,
cooling tower water.
bSwab sample of mixed hot and cold water.
cFactories, ofﬁce buildings, car wash surroundings, dental surgeries, hairdressers’ premises.
dPublic swimming pools, saunas, hotels, restaurants, sports facilities.
Table 4. Comparison of meteoro-
logical parameters on the calculated
day of Legionella infection, the day of










Average maximum day temperature (C) 15.5 22.1a 13.6 14.8
Average mean day temperature (C) 11.1 17.7a 9.5 10.6
Average relative humidity (%) 83 85a 81 82
Average no. of hours of sunshine 4.8 1.9a 4.4 4.9
aSigniﬁcant difference.
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with respect to age. L. pneumophila serogroup 1
was isolated from the environment less frequently
than expected, with only 50 isolates being cul-
tured from 6458 patient-related environmental
samples. Unfortunately, there are no previous
reports concerning prospective collections of
patient-related environmental isolates. It seems
that AFLP is sufﬁciently discriminating for the
Dutch setting, as can be inferred from the numer-
ous unique NYD AFLP types.
The present study is the ﬁrst to systematically
collect patient-related environmental samples and
Legionella isolates. The potential types of bias and
confounding that were assessed seemed to have
little effect on the principal ﬁndings of the study.
Among the weaknesses of the study is the low
number (mean 2.2) of potential sources identiﬁed
for each LD patient. Given that the patients’ own
home was one of the potential sources sampled in
91% of cases, few additional sources were
included in the study. A non-systematic study
in the UK that involved 401 unrelated LD patient
and environmental isolates revealed that some
strains were more likely to cause human infection
than would be expected from their distribution in
the environment [33]. The same conclusion was
reached by French researchers who investigated
3387 unrelated patient and environmental isolates
[36]. The present results are in accord with these
studies, but the differences between the patient
and environmental isolates identiﬁed in the pres-
ent study were more prominent.
Two possible explanations can be proposed for
these ﬁndings. First, the source investigations,
based on a standardised questionnaire, may not
identify the true sources of LD. Nevertheless, all
previously documented outbreak- or cluster-
related LD sources were included in the ques-
tionnaire. It is also reasonable to assume that the
collection of environmental isolates was repre-
sentative for the country. However, it is possible
that virulent strains should not be sought in the
aquatic environment, but rather in the air, as they
are spread by various sources on days of
increased humidity [32]. The humidity ﬁndings
seemed to conﬁrm this hypothesis, but should be
assessed using a more sophisticated analysis [37].
The second possible explanation is that the
Legionella genotypes isolated most commonly
from human respiratory secretions are also pres-
ent in the sources sampled, but at undetectable
concentrations. This alternative hypothesis is
supported by the ﬁnding that the most common
human-derived Legionella genotypes revealed in
the present study were also the only genotypes
cultured in 1999 from a display whirlpool that
caused a large outbreak of LD infection in The
Netherlands involving 188 cases. Despite exten-
sive efforts, none of the samples taken from the
efﬂuent water distribution system were found to
contain Legionella bacteria at a detectable concen-
tration. However, indirect evidence showed that
the whirlpool had been contaminated by the
building’s water supply [24]. The second hypoth-
esis is also in accord with a recent report sug-
gesting that Legionella anisa may be an indicator of
water contamination with undetectable numbers
of L. pneumophila [38], and with the concept that
the infectious dose for LD is very low, based
mainly on the observation that humans can
become infected at a distance of several hundred
metres from a source [39].
These ﬁndings require further conﬁrmation,
since this is the ﬁrst study to systematically collect
patient isolates and patient-related environmental
samples. Most importantly, there is a need to
systematically collect environmental Legionella
strains and to determine the distribution of
Legionella AFLP genotypes among LD patients in
Europe. To date, only restriction fragment-length
polymorphism results are available. It remains to
be determined whether the quotient of relative
frequencies for human and environmental
L. pneumophila isolates, as found in distributions
that have been collected systematically, is a
measure of virulence. In this respect, genotyping
of isolates using a virulence-associated epitope,
e.g., that recognised by MAb 3 ⁄ 1 (Dresden Panel)
[40], should perhaps be included in such an
evaluation.
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